Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
chlorambucil (Leukeran) (1 trial)
fludarabine (fludara) (1 trial)
Lymphoma (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Waldenstrom Macroglobulinemia (Phase 3)
Trials (1 total)
Trial APIs (2 total)